-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AgOJiqXqM8R4K/lA11Al33zPZpImif8Oiel4JdvVtXtqDmrmEYq4R+2+DO2MZsx3 sY5UmKE2lWiYDNgoQt1X7A== 0000950109-96-007105.txt : 19961106 0000950109-96-007105.hdr.sgml : 19961106 ACCESSION NUMBER: 0000950109-96-007105 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19961104 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: RENAL TREATMENT CENTERS INC /DE/ CENTRAL INDEX KEY: 0000899169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 232518331 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-10841 FILM NUMBER: 96653549 BUSINESS ADDRESS: STREET 1: 1180 WEST SWEDESFORD RD STREET 2: BLDG 2, STE 300 CITY: BERWYN STATE: PA ZIP: 19312 BUSINESS PHONE: 2156444796 MAIL ADDRESS: STREET 1: 1180 WEST SWEDESFORD ROAD BLDG 2 STREET 2: SUITE 300 CITY: BERWYN STATE: PA ZIP: 19312 424B3 1 PROSPECTUS SUPPLEMENT NO. 1 DATED NOV. 4TH, 1996 SUPPLEMENT NO. 1 DATED NOVEMBER 4, 1996 TO PROSPECTUS DATED SEPTEMBER 16, 1996 RELATING TO 482,377 SHARES OF RENAL TREATMENT CENTERS, INC. COMMON STOCK, $.01 PAR VALUE All capitalized terms used but not defined herein shall have the meanings prescribed in the Prospectus dated September 16, 1996 forming a part of Form S-3 Registration Statement No. 333-10841. Richard F. Walker, Jr., M.D., a Selling Stockholder, has transferred 110,000 of the 226,346 shares of Common Stock beneficially owned by him and covered by the Prospectus to himself and his wife, Madeleine Ann Walker, jointly, as tenants by the entireties. Dr. Walker and his spouse share voting and investment power with respect to these 110,000 shares of Common Stock, and each may be considered the beneficial owner of these 110,000 shares. Dr. Walker retains sole voting and investment power with respect to the remaining 116,346 shares of Common Stock. The definition of "Selling Stockholders" in the Prospectus is amended hereby to include Mrs. Walker. Mrs. Walker is not now, and never has been, an officer, director or employee of the Company, nor does she have any other relationship with the Company. -----END PRIVACY-ENHANCED MESSAGE-----